IGF-1 LR3
What the molecule is, where the sequence comes from, and what it binds. This page does not describe what IGF-1 LR3 does.
Structure
What IGF-1 LR3 is
Origin. A modified insulin-like growth factor 1 analog, extended at the N-terminus and substituted at position 3.
Molecular target. The IGF-1 receptor family. The modifications reduce its affinity for IGF binding proteins.
Both statements are facts about the molecule and can be checked against any reference database. Neither is a statement about an outcome, and this page makes none.
- Class
- Recombinant IGF-1 analog
- Residues
- 83
Grouped by structure
Secretagogues and analogs
Analogs of endogenous releasing hormones and their receptor ligands.
Compounds on this site are grouped by what the molecule is, not by what anyone intends to do with it. IGF-1 LR3 sits with 6 other compounds in this group because of its structure and its target, and for no other reason.
Compared side by side: IGF-1 LR3 vs Sermorelin and CJC-1295 + Ipamorelin vs IGF-1 LR3.
Read next
IGF-1 LR3 elsewhere on the site
Literature
Sources
Handling and documentation
The parts that apply to every compound
Documentation
Tested, with the certificate published
IGF-1 LR3 is tested by an independent lab. The latest certificate is on its product page.

